Yolanda Ver

9PUBLICATIONS
122CO-AUTHORS
Epidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 12, 2026
Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease.

|Jan 02, 2025
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Antonio Giordano, Isabel Pérez-Martínez, Javier P Gisbert

|May 25, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.

Celia Gómez-Labrador, Elena Ricart, Marisa Iborra

|Jul 29, 2023
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP.

Cristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill

|Feb 11, 2023
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study.

Ivan Guerra, Luis Bujanda, Miriam Mañosa

|Oct 14, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.

María Chaparro, Ana Garre, Andrea Núñez Ortiz

Pageof 2

Frequent Collaborators

7 joint publications

Javier P Gisbert

6 joint publications

Mónica Sierra-Ausin

6 joint publications

Alfredo J Lucendo

5 joint publications

María Chaparro